These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 22017298)
1. Quantification of botulinum neurotoxin serotypes A and B from serum using mass spectrometry. Parks BA; Shearer JD; Baudys J; Kalb SR; Sanford DC; Pirkle JL; Barr JR Anal Chem; 2011 Dec; 83(23):9047-53. PubMed ID: 22017298 [TBL] [Abstract][Full Text] [Related]
2. From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Boyer AE; Moura H; Woolfitt AR; Kalb SR; McWilliams LG; Pavlopoulos A; Schmidt JG; Ashley DL; Barr JR Anal Chem; 2005 Jul; 77(13):3916-24. PubMed ID: 15987092 [TBL] [Abstract][Full Text] [Related]
3. Improved detection of botulinum neurotoxin type A in stool by mass spectrometry. Wang D; Baudys J; Kalb SR; Barr JR Anal Biochem; 2011 May; 412(1):67-73. PubMed ID: 21276417 [TBL] [Abstract][Full Text] [Related]
4. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples. Kalb SR; Moura H; Boyer AE; McWilliams LG; Pirkle JL; Barr JR Anal Biochem; 2006 Apr; 351(1):84-92. PubMed ID: 16500606 [TBL] [Abstract][Full Text] [Related]
6. Multiplex detection of microbial and plant toxins by immunoaffinity enrichment and matrix-assisted laser desorption/ionization mass spectrometry. Kull S; Pauly D; Störmann B; Kirchner S; Stämmler M; Dorner MB; Lasch P; Naumann D; Dorner BG Anal Chem; 2010 Apr; 82(7):2916-24. PubMed ID: 20199054 [TBL] [Abstract][Full Text] [Related]
7. Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates. Wang D; Krilich J; Baudys J; Barr JR; Kalb SR Bioorg Med Chem; 2015 Jul; 23(13):3667-73. PubMed ID: 25913863 [TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic Activity. Kalb SR; Boyer AE; Barr JR Toxins (Basel); 2015 Aug; 7(9):3497-511. PubMed ID: 26404376 [TBL] [Abstract][Full Text] [Related]
9. Modification and validation of the Endopep-mass spectrometry method for botulinum neurotoxin detection in liver samples with application to samples collected during animal botulism outbreaks. Tevell Åberg A; Karlsson I; Hedeland M Anal Bioanal Chem; 2021 Jan; 413(2):345-354. PubMed ID: 33119784 [TBL] [Abstract][Full Text] [Related]
10. Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification. Wang D; Baudys J; Ye Y; Rees JC; Barr JR; Pirkle JL; Kalb SR Anal Biochem; 2013 Jan; 432(2):115-23. PubMed ID: 23017875 [TBL] [Abstract][Full Text] [Related]
11. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR PLoS One; 2010 Aug; 5(8):e12237. PubMed ID: 20808925 [TBL] [Abstract][Full Text] [Related]
13. Further optimization of peptide substrate enhanced assay performance for BoNT/A detection by MALDI-TOF mass spectrometry. Wang D; Baudys J; Hoyt KM; Barr JR; Kalb SR Anal Bioanal Chem; 2017 Aug; 409(20):4779-4786. PubMed ID: 28573317 [TBL] [Abstract][Full Text] [Related]
14. Direct biosensor detection of botulinum neurotoxin endopeptidase activity in sera from patients with type A botulism. Lévêque C; Ferracci G; Maulet Y; Mazuet C; Popoff M; Seagar M; El Far O Biosens Bioelectron; 2014 Jul; 57():207-12. PubMed ID: 24583693 [TBL] [Abstract][Full Text] [Related]
15. A new peptide substrate for enhanced botulinum neurotoxin type B detection by endopeptidase-liquid chromatography-tandem mass spectrometry/multiple reaction monitoring assay. Rosen O; Feldberg L; Gura S; Zichel R Anal Biochem; 2015 Mar; 473():7-10. PubMed ID: 25277815 [TBL] [Abstract][Full Text] [Related]
16. Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics. Kalb SR; Goodnough MC; Malizio CJ; Pirkle JL; Barr JR Anal Chem; 2005 Oct; 77(19):6140-6. PubMed ID: 16194071 [TBL] [Abstract][Full Text] [Related]
17. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. Kalb SR; Lou J; Garcia-Rodriguez C; Geren IN; Smith TJ; Moura H; Marks JD; Smith LA; Pirkle JL; Barr JR PLoS One; 2009; 4(4):e5355. PubMed ID: 19399171 [TBL] [Abstract][Full Text] [Related]
18. A label-free biosensor assay for botulinum neurotoxin B in food and human serum. Ferracci G; Marconi S; Mazuet C; Jover E; Blanchard MP; Seagar M; Popoff M; Lévêque C Anal Biochem; 2011 Mar; 410(2):281-8. PubMed ID: 21134347 [TBL] [Abstract][Full Text] [Related]
19. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A. Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358 [TBL] [Abstract][Full Text] [Related]
20. Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples. Kalb SR; Baudys J; Wang D; Barr JR Toxins (Basel); 2015 May; 7(5):1765-78. PubMed ID: 25996606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]